The collected research, FHS 100K, is the result of cooperation among several research institutions including Boston University School of Medicine and Public Health; the National Heart, Lung and Blood Institute (NHLBI); the National Library of Medicine; and the National Center for Biotechnology Information (NCBI).
FHS 100K will be given unprecedented availability via BioMed Central's open access journal and through NCBI's Database of Genotypes and Phenotypes (dbGaP) http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007. The researchers' decision to publish in BioMed Central's open access journal underlines their collective belief that genetic observations from FHS should be made publicly available and remain an unpatented data resource designed to accelerate scientific discovery.
"BMC Medical Genetics is honored to be the journal which presents these exciting new results to the world," said Melissa Norton, Editor-in-Chief of BMC Medical Genetics. "Inclusion in both our open access journal and in dbGaP will ensure the widest possible access to these materials and will allow researchers to more easily identify high priority findings for replication to build upon the new findings."
The FHS 100K takes its title from the high resolution 100K Affymetrix GeneChip, designed to contain the genetic sequence array of up 100,000 DNA sequences known as single-nucleotide polymorphisms (SNPs). FHS collaborators studied genetic traits, known as phenotypes, and established 8 larger Phenotype Working Groups, overseeing 17 different trait areas including cardiovascular risk factors and biomarkers; subclinical and clinical cardiovascular disease; cancer and longevity; and pulmonary, sleep, neurology, renal and bone domains. Each research article published in the supplement corresponds with one of these areas.
No other study in history has analyzed as many different phenotypic domains as FHS 100K. In addition, many phenotype samples collected through FHS were gathered years before modern therapy and remain undistorted by the effects of contemporary medical treatments, offering pristine samples unattainable in contemporary subjects.
"The Framingham Heart Study 100K effort was made possible by the generosity of our participants who have received examinations and surveillance for almost 60 years," said Dr. Emelia Benjamin, Professor of Medicine at Boston University School of Medicine (BUSM), and Director of the Echocardiography and Vascular Function laboratories at the Framingham Heart Study
Karen Antman, MD, dean of BUSM and provost of Boston University Medical Campus, added, "The Framingham Heart Study dataset is another example of the groundbreaking collaboration of researchers from Boston University Schools of Medicine and Public Health and from the NHLBI. Our researchers make extraordinary contributions that continuously improve the well-being of people all over the world."
Launched in 1948 by National Heart Institute (now NHLBI), the objective of the Framingham Heart Study is to identify the common factors or characteristics that contribute to cardiovascular disease (CVD) by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke. The original researchers recruited 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts. Those participants have been followed for nearly 60 years and FHS now includes second and third generation participants.
The data from all of the studies will be made available through NHLBI's dbGaP, a database designed to archive and distribute data from genome wide association studies. Researchers around the world will be able to use the results in the database to conduct further research to create new drugs and treatments to benefit patients. In addition, the results from FHS 100K will automatically be transferred from dbGaP into the SNP Health Association Resource (SHARe) project website, a similar database from NHLBI designed for much larger-scale, whole-genome association study. The SHARe project will analyze 550K SNPs in more than 9,000 samples collected by the NHLBI and Boston University School of Medicine for the Framingham Heart Study.
Charlotte Webber | alfa
Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung
High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences